Literature DB >> 30068023

Comparison of quantitative real-time PCR and short-term (18-hour) microculture in diagnosis of fetal cytomegalovirus infection: Impact of hyperimmunoglobulin treatment.

Lukas Penka1, Karl-Oliver Kagan2, Rangmar Goelz3, Klaus Hamprecht1.   

Abstract

OBJECTIVE: The prognostic value of human cytomegalovirus detection (HCMV) DNA levels from amniotic fluid (AF) for the outcome of the infected newborn is still a matter of debate, especially if the onset of maternal primary infection at amniocentesis is unknown. The objective of this study was to investigate the analytical performance in short-term (18-hour) microculture from preconcentrated samples and quantitative real-time PCR (rtPCR) for diagnosis of fetal HCMV infection.
METHODS: A retrospective diagnostic study was conducted on 51 AF samples taken from women that transmitted HCMV prenatally. Amniocentesis was performed around 22-week gestation. The samples were tested for HCMV viral load via quantitative rtPCR and additionally with quantitative short-term (18-hour) microculture following preconcentration via a 50 000 g centrifugation step prior to inoculation to fibroblast monolayers.
RESULTS: Both methods show correlating results (ρ = 0.903). In 25 samples, the women received intravenous hyperimmunoglobulin prior to amniocentesis resulting in a lower correlation of both quantitative methods (ρ = 0.445), in reduced median copy numbers of HCMV DNA (P = .037) and reduced viral infectivity in short-term microculture (P = .025).
CONCLUSION: Both methods lead to correlating results using AF samples from HIG-naïve women. Human cytomegalovirus viral load and infectivity in cell culture are reduced in samples following maternal hyperimmunoglobulin treatment.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30068023     DOI: 10.1002/pd.5338

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Enhanced Serum Levels of sFlt1: Impact on Materno-Fetal CMV Transmission.

Authors:  Lukas Penka; Karl-Oliver Kagan; Klaus Hamprecht
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

2.  Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas.

Authors:  Takako Tabata; Matthew Petitt; Julia Li; Xiaoyuan Chi; Wei Chen; Irina Yurgelonis; Sabine Wellnitz; Simon Bredl; Tiago Vicente; Xinzhen Yang; Philip R Dormitzer; Lenore Pereira
Journal:  Vaccines (Basel)       Date:  2022-07-04

Review 3.  Congenital Human Cytomegalovirus Infection Inducing Sensorineural Hearing Loss.

Authors:  Wenwen Xia; Hui Yan; Yiyuan Zhang; Congcong Wang; Wei Gao; Changning Lv; Wentao Wang; Zhijun Liu
Journal:  Front Microbiol       Date:  2021-04-14       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.